Scientists' expanding knowledge and understanding of stem cells is transforming the way we research human biology and medicine. Stem cells provide unique "native" human cell types that give researchers new opportunities to study targets and pathways relevant to disease processes. They offer a more reliable model to identify and confirm new drug targets and generate pharmacology and toxiciology breakthroughs with strong translation to the clinical setting. Additionally, the application of stem cells in drug development creates a new path to personalized medicine, while at the same time reduces, or even potentially replaces, animal testing.
We help scientists make the most of these new opportunities. Our customers make exciting discoveries every day using cellular imaging platforms such as ImageXpress® Micro XLS System and SpectraMax® MiniMax™ 300 Imaging Cytometer, or our electrophysiology and plate reader systems along with optimized reagents and consumables.
- High Throughput Cardiotoxicity Assays Using Stem Cell-Derived Cardiomyocytes
- High Content Screening of Neuronal Toxicity Using iPSC-Derived Human Neurons
- EarlyTox Cardiotoxicity Kit Provides Biologically Relevant Cardiotoxicity Data Earlier in the Drug Discovery Process
- Cardiomyocyte Beating and Cytotoxicity Assays on the SpectraMax i3 Multi-Mode Microplate Platform with SpectraMax MiniMax Imaging Cytometer